All PlansCoverageMedium impact
Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
Blue Cross & Blue Shield of Mississippi·MS · Psychiatry, Neurology·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy establishes medical necessity criteria for Transcranial Magnetic Stimulation (TMS) treatment of major depressive disorder using FDA-cleared devices. Coverage requires confirmed severe depression diagnosis with standardized rating scales and failure of at least 2 antidepressant trials from different classes, or medication intolerance.
Action Required
Immediately: Billing team must verify TMS claims meet all medical necessity criteria before submission. Ensure documentation includes: 1) Standardized depression rating scales confirming severe major depressive disorder, 2) Records of 2 failed antidepressant trials from different classes (6+ weeks each at therapeutic doses with ≥80% adherence) OR documented medication intolerance, 3) Confirmation that FDA-cleared TMS device/modality was used. Claims without complete documentation will likely be denied.